Lung cancer is a commonly diagnosed disease with poor prognosis. Novel therapeutic targets and deep understanding of the regulatory mechanisms in lung cancer are of great importance. We aimed to… Click to show full abstract
Lung cancer is a commonly diagnosed disease with poor prognosis. Novel therapeutic targets and deep understanding of the regulatory mechanisms in lung cancer are of great importance. We aimed to figure out the functional roles of lncRNA‐activated by transforming growth factor‐β (ATB) in A549 cells as well as the underlying molecular mechanisms. ATB was non‐physiologically expressed in A549 cells after cell transfection. Then, cell proliferation, expressions of proteins related to proliferation and epithelial‐mesenchymal transition (EMT), migration, and invasion were measured by BrdU incorporation assay, Western blot analysis, and Transwell assay, respectively. Afterwards, miR‐494 expression in transfected A549 cells was determined by quantitative reverse transcription PCR. Meanwhile, effects of miR‐494 overexpression on ATB‐overexpressed cells were assessed. Finally, the phosphorylation levels of AKT and key kinases in the Janus‐activated kinase (JAK)/signal transducer and activator of transcription‐3 (STAT3) pathway were detected by Western blot analysis. ATB overexpression promoted proliferation, migration, and invasion of A549 cells. Meanwhile, EMT of A549 cells was also enhanced. ATB silence showed the opposite influence. Expression of miR‐494 was negatively regulated by ATB. Following experiments showed ATB‐induced alterations of proliferation, migration, invasion, and EMT were all reversed by miR‐494 overexpression. Finally, we proved that ATB increased phosphorylated levels of AKT, JAK1, and STAT3, and those increases were all reversed by miR‐494 overexpression. We interestingly figured out that ATB promoted proliferation, migration, invasion, and EMT through down‐regulating miR‐494 in A549 cells. Moreover, ATB might activate AKT and the JAK/STAT3 pathway via down‐regulating miR‐494.
               
Click one of the above tabs to view related content.